All Type of News
CrystalGenomics makes trademark application of ‘Acelex’ in 35 countries
CrystalGenomics (CEO Joong-Myung Cho) announced on the 31st that the ‘Acelex(generic name: polmacixib)’ trademark right has been applied in 35 countries in the world.
According to the company, the trademark applicati...
Government allows Korean pharmaceutical companies to manufacture foreign new drugs and orphan drugs under contract
New drugs and orphan drugs whose technology transferred to a Korean manufacturer if sold in other countries will now be available to manufacturer under contract even in Korea.
As the Pharmaceutical Affairs Law is rev...
192 medicines approved this January and pouring generic drugs
There were total 192 products approved as medicine this January, and 85% of them were generic drugs referencing an original drug.
According to the Ministry of Food and Drug Safety Online Drug Library, there were 145 ...
‘Kyprolis’ receives health insurance benefits with RSA from 5 February
‘Kyprolis Inj,’ an Amgen’s multiple myeloma therapy, has passed the Health Insurance Policy Deliberation Committee
Along with enforcement of the life-prolonging treatment, the government will also carry out other pla...
Mass drug price cuts create conflicts between pharmas and distributors
As the drug price cut was applied on 3,619 products on the 1st, pharmaceutical distribution companies have raised complaints about increased workloads in regards to balancing price differences.
In this process, some ...
Last year, 471 pharmacies closed while 561 newly opened in Seoul
Last year, 561 pharmacies reportedly were newly opened and 471 were closed in Seoul.
According to the opening and closing status of medical institutes researched by the Health Insurance Review & Assessment Service, t...
Government to impose disciplinary fine for falsely reporting adverse drug reactions in clinical trials
If an institute or organization is exposed for a false report of adverse drug reactions during a clinical trial, a disciplinary fine will be imposed.
In order to keep patients participating in clinical trials safe an...
HIRA busy with the plan to give health insurance benefits on uninsured medical services
The Health Insurance Review & Assessment Service(President Seung-Taek Kim, HIRA) seems to spur on carrying out the ‘Change of Clinically Uninsured Services to Insured.’
In the materials for the National Assembly work...
Endless shortages of medicines due to ingredient supply problem and market evacuation
Even at the beginning of this year, there have been a number of medicine supply suspension due to various reasons, such as supply problem for ingredients and competing products’ market evacuation or recall.
Daihan Ph...
One after another, KPBMA to find a person for its new chairman
At this point where it has been over 10 months since Korea Pharmaceutical and Bio-Pharma Manufacturers Association(KPBMA) Chairman Hee-Mok Won was appointed, the association has to find the ‘right person’ once again a...
